Xinbang Pharmaceuticals: the company and its subsidiaries need to pay overdue taxes and penalties of 50.78 million yuan.

Xinbang Pharmaceutical announced on January 25th that, after self-inspection, the company and its subsidiaries need to make up for a total of 50.78 million yuan in taxes and late fees. The aforementioned amount of taxes and late fees will be recorded in the company's 2025 current profit and loss statement.